Usefulness of cancer-free survival in estimating the lifetime attributable risk of cancer incidence from radiation exposure
- Authors
- Seo, Songwon; Lee, Dal Nim; Jin, Young Woo; Lee, Won Jin; Park, Sunhoo
- Issue Date
- 9월-2018
- Publisher
- IOP PUBLISHING LTD
- Keywords
- radiation exposure; risk projection model; cancer; cancer-free survival; overall survival
- Citation
- JOURNAL OF RADIOLOGICAL PROTECTION, v.38, no.3, pp.N17 - N24
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF RADIOLOGICAL PROTECTION
- Volume
- 38
- Number
- 3
- Start Page
- N17
- End Page
- N24
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/73621
- DOI
- 10.1088/1361-6498/aac3f3
- ISSN
- 0952-4746
- Abstract
- Risk projection models estimating the lifetime cancer risk from radiation exposure are generally based on exposure dose, age at exposure, attained age, gender and study-population-specific factors such as baseline cancer risks and survival rates. Because such models have mostly been based on the Life Span Study cohort of Japanese atomic bomb survivors, the baseline risks and survival rates in the target population should be considered when applying the cancer risk. The survival function used in the risk projection models that are commonly used in the radiological protection held to estimate the cancer risk from medical or occupational exposure is based on all-cause mortality. Thus, it may not be accurate for estimating the lifetime risk of high-incidence but not life-threatening cancer with a long-term survival rate. Herein, we present the lifetime attributable risk (LAR) estimates of all solid cancers except thyroid cancer, thyroid cancer, and leukemia except chronic lymphocytic leukemia in South Korea for lifetime exposure to 1 mGy per year using the cancer-free survival function, as recently applied in the Fukushima health risk assessment by the World Health Organization. Compared with the estimates of LARs using an overall survival function solely based on all-cause mortality, the LARs of all solid cancers except thyroid cancer, and thyroid cancer evaluated using the cancer-free survival function, decreased by approximately 13% and 1% for men and 9% and 5% for women, respectively. The LAR of leukemia except chronic lymphocytic leukemia barely changed for either gender owing to the small absolute difference between its incidence and mortality. Given that many cancers have a high curative rate and low mortality rate, using a survival function solely based on all-cause mortality may cause an over-estimation of the lifetime risk of cancer incidence. The lifetime fractional risk was robust against the choice of survival function.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.